Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W B Peeling

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The Prostate|January 1, 1993
An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumorsM E Harper, L Goddard, E Glynne-Jones, et al.
The Prostate|January 1, 1992
Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinomaM E Harper, L Goddard, D W Wilson, et al.
British Journal of Urology|May 1, 1987
The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI 118630C J Beacock, A C Buck, R Zwinck, et al.
Progress in Clinical and Biological Research|January 1, 1985
Endocrine factors in the treatment of prostatic cancerC G Pierrepoint, A O Turkes, K J Walker, et al.
The Journal of Endocrinology|November 1, 1984
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex)K J Walker, A O Turkes, A Turkes, et al.
Clinical Radiology|September 1, 1984
Ultrasonic appearances associated with prostatic inflammation: a preliminary studyG J Griffiths, A J Crooks, E E Roberts, et al.
Acta Endocrinologica|February 1, 1976
Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapyM E Harper, W B Peeling, T Cowley, et al.
The Prostate|January 1, 1992
Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parametersM E Harper, E Glynne-Jones, L Goddard, et al.
The Prostate|January 1, 1985
A prognostic index for the clinical management of patients with advanced prostatic cancer: a British Prostate Study Group investigationD W Wilson, M E Harper, H M Jensen, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Prevalence of prostatic intra-epithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: clinical implicationsM R Feneley, J S A Green, M P A Young, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Prostate|January 1, 1993
An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumorsM E Harper, L Goddard, E Glynne-Jones, et al.
The Prostate|January 1, 1992
Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinomaM E Harper, L Goddard, D W Wilson, et al.
British Journal of Urology|May 1, 1987
The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI 118630C J Beacock, A C Buck, R Zwinck, et al.
Progress in Clinical and Biological Research|January 1, 1985
Endocrine factors in the treatment of prostatic cancerC G Pierrepoint, A O Turkes, K J Walker, et al.
The Journal of Endocrinology|November 1, 1984
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex)K J Walker, A O Turkes, A Turkes, et al.
Clinical Radiology|September 1, 1984
Ultrasonic appearances associated with prostatic inflammation: a preliminary studyG J Griffiths, A J Crooks, E E Roberts, et al.
Acta Endocrinologica|February 1, 1976
Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapyM E Harper, W B Peeling, T Cowley, et al.
The Prostate|January 1, 1992
Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parametersM E Harper, E Glynne-Jones, L Goddard, et al.
The Prostate|January 1, 1985
A prognostic index for the clinical management of patients with advanced prostatic cancer: a British Prostate Study Group investigationD W Wilson, M E Harper, H M Jensen, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Prevalence of prostatic intra-epithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: clinical implicationsM R Feneley, J S A Green, M P A Young, et al.
Pageof 8